These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 33875373)

  • 1. Valproate but not levetiracetam slows the EEG alpha peak frequency - A pharmaco-EEG study.
    Zöllner JP; Strzelczyk A; Rosenow F; Kienitz R
    Clin Neurophysiol; 2021 Jun; 132(6):1203-1208. PubMed ID: 33875373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial levetiracetam versus valproate monotherapy in antiseizure medicine (ASM)-naïve pediatric patients with idiopathic generalized epilepsy with tonic-clonic seizures.
    Abdelmesih SK; Elkhateeb N; Zakaria M; Girgis MY
    Seizure; 2021 Oct; 91():263-270. PubMed ID: 34246881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resting-state fMRI revealed different brain activities responding to valproic acid and levetiracetam in benign epilepsy with central-temporal spikes.
    Zhang Q; Yang F; Hu Z; Zhang Z; Xu Q; Dante M; Wu H; Li Z; Li Q; Li K; Lu G
    Eur Radiol; 2017 May; 27(5):2137-2145. PubMed ID: 27553940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of levetiracetam for reducing rolandic discharges in comparison with carbamazepine and valproate sodium in rolandic epilepsy.
    Kanemura H; Sano F; Ohyama T; Aihara M
    Seizure; 2018 Nov; 62():79-83. PubMed ID: 30308427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of valproate, lamotrigine, and levetiracetam monotherapy on bone health in newly diagnosed adult patients with epilepsy.
    Guo Y; Lin Z; Huang Y; Yu L
    Epilepsy Behav; 2020 Dec; 113():107489. PubMed ID: 33220583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats.
    van Vliet EA; Edelbroek PM; Gorter JA
    Epilepsia; 2010 Mar; 51(3):362-70. PubMed ID: 19674045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring the effects of first antiepileptic medication in Temporal Lobe Epilepsy: Predictive value of quantitative-EEG analysis.
    Ricci L; Assenza G; Pulitano P; Simonelli V; Vollero L; Lanzone J; Mecarelli O; Di Lazzaro V; Tombini M
    Clin Neurophysiol; 2021 Jan; 132(1):25-35. PubMed ID: 33248432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of levetiracetam monotherapy on background EEG activity and cognition in drug-naïve epilepsy patients.
    Cho JR; Koo DL; Joo EY; Yoon SM; Ju E; Lee J; Kim DY; Hong SB
    Clin Neurophysiol; 2012 May; 123(5):883-91. PubMed ID: 22000706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in the choice of antiseizure medications in juvenile myoclonic epilepsy: A retrospective multi-center study from Turkey between 2010 and 2020.
    Kılıç B; Serdaroğlu E; Polat BG; İnce T; Esenülkü G; Topçu Y; Serdaroğlu A; Haspolat Ş; Tekgül H; Okuyaz Ç; Cansu A; Aydın K
    Seizure; 2022 Jul; 99():48-53. PubMed ID: 35594744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levetiracetam in genetic generalized epilepsy: A prospective unblinded active-controlled trial.
    Tabrizi N; Zarvani A; Rezaei P; Cheraghmakani H; Alizadeh-Navaei R
    Epilepsy Res; 2019 Nov; 157():106214. PubMed ID: 31627041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproate treatment normalizes EEG functional connectivity in successfully treated idiopathic generalized epilepsy patients.
    Clemens B; Puskás S; Besenyei M; Kovács NZ; Spisák T; Kis SA; Emri M; Hollódy K; Fogarasi A; Kondákor I; Fekete I
    Epilepsy Res; 2014 Dec; 108(10):1896-903. PubMed ID: 25454501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levetiracetam and Valproate Retention Rate in Juvenile Myoclonic Epilepsy.
    Sala-Padró J; Toledo M; Santamarina E; González-Cuevas M; Raspall-Chaure M; Sueiras-Gil M; Quintana M; Salas-Puig X
    Clin Neuropharmacol; 2016; 39(6):299-301. PubMed ID: 27438183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.
    Trinka E; Marson AG; Van Paesschen W; Kälviäinen R; Marovac J; Duncan B; Buyle S; Hallström Y; Hon P; Muscas GC; Newton M; Meencke HJ; Smith PE; Pohlmann-Eden B;
    J Neurol Neurosurg Psychiatry; 2013 Oct; 84(10):1138-47. PubMed ID: 22933814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-lasting antiepileptic effects of levetiracetam against epileptic seizures in the spontaneously epileptic rat (SER): differentiation of levetiracetam from conventional antiepileptic drugs.
    Ji-qun C; Ishihara K; Nagayama T; Serikawa T; Sasa M
    Epilepsia; 2005 Sep; 46(9):1362-70. PubMed ID: 16146430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressive effects of levetiracetam on neuroinflammation and phagocytic microglia: A comparative study of levetiracetam, valproate and carbamazepine.
    Itoh K; Taniguchi R; Matsuo T; Oguro A; Vogel CFA; Yamazaki T; Ishihara Y
    Neurosci Lett; 2019 Aug; 708():134363. PubMed ID: 31276728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D deficiency in children with epilepsy taking valproate and levetiracetam as monotherapy.
    Durá-Travé T; Gallinas-Victoriano F; Malumbres-Chacón M; Moreno-Gónzalez P; Aguilera-Albesa S; Yoldi-Petri ME
    Epilepsy Res; 2018 Jan; 139():80-84. PubMed ID: 29197669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of levetiracetam, carbamazepine, and sodium valproate on P100 and P300 in epileptic patients.
    Tumay Y; Altun Y; Ekmekci K; Ozkul Y
    Clin Neuropharmacol; 2013; 36(2):55-8. PubMed ID: 23503548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of in utero exposure to valproate or levetiracetam on the seizures and newborn histopathology of genetic absence epilepsy rats.
    Can Kantarci B; Sanli A; Gavas S; Toplu A; Nur Turgan Asik Z; Tugce Cilingir-Kaya O; Gulcebi Idrizoglu M; Ercan F; Onat F
    Neurosci Lett; 2022 Apr; 776():136574. PubMed ID: 35271996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add-on therapy compared to levetiracetam and valproic acid.
    Liguori C; Turner K; Izzi F; Assogna M; Canevini MP; Mercuri NB; Placidi F
    CNS Neurosci Ther; 2019 May; 25(5):632-637. PubMed ID: 30675751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effectiveness of levetiracetam, valproate and carbamazepine among elderly patients with newly diagnosed epilepsy: subgroup analysis of the randomized, unblinded KOMET study.
    Pohlmann-Eden B; Marson AG; Noack-Rink M; Ramirez F; Tofighy A; Werhahn KJ; Wild I; Trinka E
    BMC Neurol; 2016 Aug; 16(1):149. PubMed ID: 27552848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.